Assessing 2024 oncology advances and looking ahead Editorial


Author: Iyengar, N. M.
Title: Assessing 2024 oncology advances and looking ahead
Keywords: antineoplastic agents; drug approval; tyrosine kinase inhibitors; protein kinase inhibitors; antibodies, monoclonal; dna; immunotherapy; artificial intelligence; patient-reported outcomes; trastuzumab; early detection of cancer; information technology; neoplasms -- therapy; neoplasms -- diagnosis; machine learning; oncologic care; liquid biopsy -- methods; glucagon-like peptide-1 receptor agonists
Journal Title: Oncology (Norwalk)
Volume: 38
Issue: 12
ISSN: 0890-9091
Publisher: C M P Medica LLC * The Oncology Group  
Date Published: 2024-12-01
Start Page: 457
Language: English
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
DOI/URL:
Notes: Accession Number: 181425259 -- Entry Date: 20241212 -- Revision Date: 20241212 -- Publication Type: Journal Article; letter -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- Special Interest: Oncologic Care -- NLM UID: 8712059. -- Source: CINAHL Plus with Full Text
MSK Authors
  1. Neil Mukund Iyengar
    152 Iyengar